These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4808472)

  • 1. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines.
    Schaeffer HJ; Schwender CF
    J Med Chem; 1974 Jan; 17(1):6-8. PubMed ID: 4808472
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzyme inhibitors. 25. An equation to calculate the unknown K i from two known values of K i in an R,S, and RS series. Stereoselectivity of inhibition of Adenosine deaminase by (R)-, (S)-, and (RS)-9-(1-hydroxy-2-alkyl and -aralkyl)adenines.
    Schaeffer HJ; Johnson RN; Schwartz MA; Schwender CF
    J Med Chem; 1972 May; 15(5):456-8. PubMed ID: 5064317
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme inhibitors. XX. Studies on the hydrophobic and hydroxyl binding regions of adenosine deaminase. 9-(2-m-Bromoacetamidophenethyl)adenine, a new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Johnson RN
    J Med Chem; 1968 Jan; 11(1):21-6. PubMed ID: 5637186
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of adenosine deaminase by alcohols derived from adenine nucleosides.
    Lerner LM; Rossi RR
    Biochemistry; 1972 Jul; 11(15):2772-7. PubMed ID: 4339466
    [No Abstract]   [Full Text] [Related]  

  • 5. Competitive inhibition of adenosine deaminase by urea and amidine derivatives.
    Ronca G; Ronca-Testoni S
    Biochim Biophys Acta; 1969 May; 178(3):577-87. PubMed ID: 5814727
    [No Abstract]   [Full Text] [Related]  

  • 6. A general method of purification of adenosine deaminase by affinity chromatography.
    Rossi CA; Lucacchini A; Montali U; Ronca G
    Int J Pept Protein Res; 1975; 7(1):81-9. PubMed ID: 1120633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme inhibitors XXIV: bridging hydrophobic and hydrophilic regions on adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1971 Aug; 60(8):1204-8. PubMed ID: 5156472
    [No Abstract]   [Full Text] [Related]  

  • 8. Substrate properties of cycloadenosines with adenosine aminohydrolase as evidence for the conformation of enzyme-bound adenosine.
    Hampton A; Harper PJ; Sasaki T
    Biochemistry; 1972 Dec; 11(25):4736-9. PubMed ID: 4676271
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine deaminase inhibitors. Synthesis and biological evaluation of C1' and nor-C1' derivatives of (+)-erythro-9-(2(S)-hydroxy-3(R)-nonyl)adenine.
    Harriman GC; Poirot AF; Abushanab E; Midgett RM; Stoeckler JD
    J Med Chem; 1992 Oct; 35(22):4180-4. PubMed ID: 1433220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships in adenosine deaminase inhibitors.
    Schaeffer HJ; Johnson RN; Odin E; Hansch C
    J Med Chem; 1970 May; 13(3):452-5. PubMed ID: 5441130
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel substrate of adenosine deaminase.
    Ogilvie KK; Slotin L; Rheault P
    Biochem Biophys Res Commun; 1971 Oct; 45(2):297-300. PubMed ID: 5168598
    [No Abstract]   [Full Text] [Related]  

  • 12. Alkylation of adenosine deaminase by benzylbromoacetate and 9-(p-bromoacetamidobenzyl)adenine.
    Ronca G; Saettone MF; Lucacchini A
    Biochim Biophys Acta; 1970 Jun; 206(3):414-25. PubMed ID: 5459550
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the specificity and mechanism of action of adenosine deaminase.
    Baer HP; Drummond GI; Gillis J
    Arch Biochem Biophys; 1968 Jan; 123(1):172-8. PubMed ID: 5689048
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine deaminase inhibitors. Synthesis and biological evaluation of 4-amino-1-(2(S)-hydroxy-3(R)-nonyl)-1H-imidazo[4,5-c]pyridine (3-deaza-(+)-EHNA) and certain C1' derivatives.
    Harriman GC; Abushanab E; Stoeckler JD
    J Med Chem; 1994 Jan; 37(2):305-8. PubMed ID: 8295218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme inhibitors. XXI. Hydrophobic and hydroxylic binding sites of adenosine deaminase.
    Schaeffer HJ; Schwender CF
    J Pharm Sci; 1967 Dec; 56(12):1586-90. PubMed ID: 5588708
    [No Abstract]   [Full Text] [Related]  

  • 16. Specificity of inhibition of adenosine deaminase by trialcohols derived from nucleosides.
    Rossi RR; Lerner LM
    J Med Chem; 1973 May; 16(5):457-60. PubMed ID: 4718455
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of substituted 1,2,3-triazoles on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Segnini D; Da Settimo A; Livi O
    Ital J Biochem; 1979; 28(3):194-206. PubMed ID: 583599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemistry and pharmacology of apiose. 7. Susceptibility of some branched-chain sugar nucleosides to enzymatic deamination.
    Tronchet JM; Tronchet J; Graf R
    J Med Chem; 1974 Oct; 17(10):1055-6. PubMed ID: 4472858
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
    Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
    J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine deaminase inhibitors. Synthesis and biological evaluation of putative metabolites of (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine.
    Vargeese C; Sarma MS; Pragnacharyulu PV; Abushanab E; Li SY; Stoeckler JD
    J Med Chem; 1994 Oct; 37(22):3844-9. PubMed ID: 7966142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.